We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.00 | 29.09% | 17.75 | 17.00 | 18.50 | 18.25 | 15.25 | 16.25 | 7,554,983 | 16:29:58 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -2.13 | 46.25M |
TIDMAGL
RNS Number : 4527B
Angle PLC
04 April 2017
For immediate release 4 April 2017
ANGLE plc ("the Company")
Holding(s) in Company
The Company has been informed by Lombard Odier Investment Managers group ("Lombard") that, following its recent acquisition of Henderson Volantis from Henderson Global plc ("Henderson"), Lombard has acquired ordinary shares in the Company via an in-specie transfer of accounts managed by Henderson on a discretionary basis to Lombard. Further information is set out below.
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or ANGLE Plc the underlying issuer of existing shares to which voting rights are attached: (ii) ------------------------------------------------------------- ---------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights --------------------------------------------------------------------------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------------------------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments --------------------------------------------------------------------------------------------------------- An event changing the breakdown of voting rights --------------------------------------------------------------------------------------------------------- Other (please Transfer of accounts managed on a X specify): discretionary basis by Henderson Group Plc to Lombard Odier Investment Managers group --------------------------------------------------------- ---------------------------------------------- 3. Full name of person(s) Lombard Odier Asset Management subject to the (Europe) Limited notification obligation: (iii) ----------------------------------------------------------- ------------------------------------------------ 4. Full name of shareholder(s) Disclosure on behalf of accounts (if different from 3.):(iv) managed on a discretionary basis by Lombard Odier Investment Managers group. ----------------------------------------------------------- ------------------------------------------------ 5. Date of the transaction 01/04/2017 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ------------------------------------------------ 6. Date on which issuer 03/04/2017 notified: ----------------------------------------------------------- ------------------------------------------------ 7. Threshold(s) that is/are above 5% crossed or reached: (vi, vii) ----------------------------------------------------------- ------------------------------------------------ 8. Notified details: --------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) --------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- ------------------------------ --------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights -------------- -------------- -------------- ------------- --------------------- ------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ------------ ------------ ------------- --------- ---------- -------- --------- GB0034330679 5,899,164 7.88% ---------- -------- --------- B: Qualifying Financial Instruments --------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction --------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ---------------- ------------- ----------------------------- -------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) --------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction --------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ------------- ------------- -------------- --------------------- ------------------- Nominal Delta --------------- ------------- ------------- -------------- --------------------- -------- --------- Total (A+B+C) --------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ----------------------------------------------- -------------------------------------------------------- 5,899,164 7.88% ----------------------------------------------- -------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------------------- Proxy Voting: -------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ----------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ----------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ----------------- 13. Additional information: ------------------------------------------------------------- ----------------- 14. Contact name: Kiran Bassi ------------------------------------------------------------- ----------------- 15. Contact telephone number: +44 20 3206 6000 ------------------------------------------------------------- ----------------- TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or ANGLE Plc the underlying issuer of existing shares to which voting rights are attached: (ii) ------------------------------------------------------------- --------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights -------------------------------------------------------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------------------------- An event changing the breakdown of voting rights -------------------------------------------------------------------------------------- Other (please In specie transfer out X specify): --------------------------------------------------------- --------------------------- 3. Full name of person(s) Henderson Group plc subject to the notification obligation: (iii) ----------------------------------------------------------- ----------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ----------------------------------------------------------- ----------------------------- 5. Date of the transaction 31 March 2017 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ----------------------------- 6. Date on which issuer 3 April 2017 notified: ----------------------------------------------------------- ----------------------------- 7. Threshold(s) that is/are Below 5% crossed or reached: (vi, vii) ----------------------------------------------------------- ----------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- -------------------------- -------------------------------------------------------- Number Number Number Number of % of voting of of of voting rights (x) Shares Voting shares rights Rights -------------- ------------ ------------ ------------ --------------------- ------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ------------ ------------ ------------ ------- ------------ -------- --------- Below Below Ordinary 4,205,074 4,205,074 5% 5% ------------ ------------ ------------ ------- ------------ -------- --------- GB0034330679 -------------- ------------ ------------ ------------ ------- ------------ -------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. -------------- ------------ -------------------------- --------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) -------------- ------------ ------------ ------------ --------------------- ------------------- Nominal Delta -------------- ------------ ------------ ------------ --------------------- -------- --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------ -------------------------------------------------------- Below 5% Below 5% ------------------------------------------ -------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ----------------------------------------------------------------------------------------------------- See Annex 1 below. Proxy Voting: ----------------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- -------------------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- -------------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- -------------------------------------- 13. Additional information: ------------------------------------------------------------- -------------------------------------- 14. Contact name: HGIThresholdDisclosures@henderson.com ------------------------------------------------------------- -------------------------------------- 15. Contact telephone number: 020 7818 1818 ------------------------------------------------------------- -------------------------------------- Annex 1: Information in relation to the person subject to the notification obligation (please tick the applicable box): [ ] Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.(xiii) [X] Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity(xiv) : Name(xv) % of voting % of voting Total of both rights if it rights through if it equals equals or is financial instruments or is higher higher than if it equals than the notifiable the notifiable or is higher threshold threshold than the notifiable threshold ---------------------- ---------------- ----------------------- --------------------- Henderson Group Below 5% - Below 5% plc, Henderson Group Holdings Asset Management Limited, HGI Asset Management Group Limited, Henderson Global Group Limited, Henderson Holdings Group Limited, HGI Group Limited, Henderson Global Investors (Holdings) Limited, AlphaGen Capital Limited ---------------------- ---------------- ----------------------- --------------------- Henderson Group Below 5% - Below 5% plc, Henderson Group Holdings Asset Management Limited, HGI Asset Management Group Limited, Henderson Global Group Limited, Henderson Holdings Group Limited, HGI Group Limited, Henderson Global Investors (Holdings) Limited, Henderson Global Investors Limited ---------------------- ---------------- ----------------------- ---------------------
For further information:
ANGLE plc 01483 685830 Andrew Newland, Chief Executive Ian Griffiths, Finance Director Cenkos Securities Stephen Keys (Nominated adviser), Steve Cox Russell Kerr (Sales) 020 7397 8900 WG Partners David Wilson Claes Spång 020 3705 9330 FTI Consulting Simon Conway, Mo Noonan, Stephanie Cuthbert 020 3727 1000 Kimberly Ha (US) 001 212 850 5612
For Frequently Used Terms, please see the Company's website on http://www.angleplc.com/the-parsortix-system/glossary/
Notes for editors
About ANGLE plc www.angleplc.com
ANGLE is a specialist medtech company commercialising a disruptive platform technology that can capture cells circulating in blood, such as cancer cells, even when they are as rare in number as one cell in one billion blood cells, and harvest the cells for analysis.
ANGLE's cell separation technology is called the Parsortix(TM) system and it enables a liquid biopsy (simple blood test) to be used to provide the cells of interest. Parsortix is the subject of granted patents in Europe, the United States, Canada, China, Japan and Australia and three extensive families of patents are being progressed worldwide. The system is based on a microfluidic device that captures live cells based on a combination of their size and compressibility. Parsortix has a CE Mark for Europe and FDA authorisation is in process for the United States.
ANGLE has established formal collaborations with world-class cancer centres. These Key Opinion Leaders are working to identify applications with medical utility (clear benefit to patients), and to secure clinical data that demonstrates that utility in patient studies. Details are available here http://www.angleplc.com/the-company/collaborators/
The analysis of the cells that can be harvested from patient blood with ANGLE's Parsortix system has the potential to help deliver personalised cancer care offering profound improvements in clinical and health economic outcomes in the treatment and diagnosis of various forms of cancer.
The global increase in cancer to a 1 in 3 lifetime incidence is set to drive a multi-billion dollar clinical market. The Parsortix system is designed to be compatible with existing major medtech analytical platforms and to act as a companion diagnostic for major pharma in helping to identify patients that will benefit from a particular drug and then monitoring the drug's effectiveness.
As well as cancer, the Parsortix technology has the potential for deployment with several other important cell types in the future.
ANGLE stock trades on the AIM market of the London Stock Exchange under the ticker symbol AGL and in New York on the OTC-QX under the ticker symbol ANPCY. For further information please visit: www.angleplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLIJMBTMBMMTIR
(END) Dow Jones Newswires
April 04, 2017 02:01 ET (06:01 GMT)
1 Year Angle Chart |
1 Month Angle Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions